Amicus Therapeutics Inc. (NASDAQ:FOLD)

Chart of the Day September 21st, 2017

View Entire Video (03:56)
Chart of the Day
September 21st, 2017
   03:51
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
FOLD Weekly Chart

Old Forum Content for FOLD

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • woodman: $FOLD weekly breakout.
  • lostsheep: $FOLD data on a potential drug with fda always risky but a interesting technical setup 14% short earnings 5/10
  • lostsheep: $FOLD spec weekly trigger above the daily 50 far from the winners circle but tight price action earnings 5/10
  • scottrades: Some #Earnings to be aware of this week: $NIO $ZM $FUBO $WKHS $MELI $TGT $SE $LMND $SNOW $DDD $NVAX $COST $MRVL $INO $BRK.B $FLGT $SDC $TGNA $TXMD $KSS $SWBI $THRM $INSG $DLTR $SPLK $WEN $ANF $SSYS $AVGO $LL $KOPN $AZO $FOLD $NRG $CWEN $KR $BJ $VRM $HEAR $PRPL $VEEV
  • Henry: $FOLD Meg T just interviewed the CEO I was not impressed when he said the mobility improvements were significant, even though they were not statistically significant. Statistics are supposed to separate fact from anecdote. And then she said he has two kids with Pompe disease and my heart melted. Probably none of the MD's in the forum have seen a case and maybe no one in the forum has.
  • issues: I like these three bio techs: $CLDX $FOLD $PCRX. The others in the IBD group include $APVO $DNLI but they are too extended. My first choice would be CLDX then FOLD and finally PCRX. Any ideas or holders?
  • issues: $BBIO looks real good. I also like these bios: $CLDX $FOLD & $PCRX but NP yet. Too extended $APVO $DNLI
  • issues: @AlexJFraser $BBIO I like this chart! It may be the right price. I can't decide between that one and one of these: $CLDX $FOLD $PCRX. NP yet
  • AlexJFraser: @issues $BBIO $CLDX $FOLD $PCRX I am most comfortable with the $bbio chart for my trading. I have been watching for a bit. Nice breakout, Earnings date isn't an issue now until next year. I got in yesterday and added a bit today. It looks like it has 16 days of short interest according to ShortSqueeze. Good luck!
  • scottrades: Some #Earnings to be aware of this week. $NIO $MELI $CGC $WKHS $GOLD $RCL $DKNG $MAR $INO $CSCO $NVAX $TLRY $MARK $PRTK $JMIA $DUK $SPG $ON $HUYA $AMAT $SDC $OXY $GBDC $SEAS $ICPT $PRPL $LYFT $BIDU $SOHU $FOLD $CEVA $DOYU $SYY $SDGR $GOOS $TTOO $SOGO $TNK $NBEV $GRWG
  • issues: @scottrades $NIO $MELI $CGC $WKHS $GOLD $RCL $DKNG $MAR $INO $CSCO $NVAX $TLRY $MARK $PRTK $JMIA $DUK $SPG $ON $HUYA $AMAT $SDC $OXY $GBDC $SEAS $ICPT $PRPL $LYFT $BIDU $SOHU $FOLD $CEVA $DOYU $SYY $SDGR $GOOS $TTOO $SOGO $TNK $NBEV $GRWG #Earnings Thanks Scotty. How do you get Earnings Whisper to email me that chart?
  • Ajax4Hire: And the complement; $XBI Bio-Technology; Bio=Life; Techno=art/craft/skill; logy=study of BioTechnoLogy=Life-Craft-Study, aren't we all bio-technologist. Hold% $XBI SPDR S&P Biotech ETF - Top 15 holdings 1.79% $NVTA Invitae Corp 1.60% $INO Inovio Pharmaceuticals Inc 1.48% $NVAX Novavax Inc 1.38% $FOLD Amicus Therapeutics Inc 1.23% $ARWR Arrowhead Pharmaceuticals Inc 1.19% $MNTA Momenta Pharmaceuticals Inc 1.17% $ALNY Alnylam Pharmaceuticals Inc 1.16% $EDIT Editas Medicine Inc 1.15% $SAGE SAGE Therapeutics Inc 1.14% $DCPH Deciphera Pharmaceuticals Inc 1.14% $IMMU Immunomedics Inc 1.14% $KPTI Karyopharm Therapeutics Inc 1.13% $ALKS Alkermes Plc 1.12% $INCY Incyte Corp 1.11% $BMRN Biomarin Pharmaceutical Inc Data from: https://ETFdB.com/etf/XBI/#holdings
  • efrain007: $FOLD might work for a trade, over Friday high.
  • baronp0329: Some earning for the week of Nov 11-15 $NVDA $WMT $CRON $CGC $CSCO $ACB $OSTK $DHI $NEPT $TLRY $JD $FOLD $GOOS $TSN $AAP $SWKS $JCP $AMAT $LK $CBS $SE $NBEV $DXC $HUYA $TME $YY $CGEN $CTEK $QRTEA $HIIQ $DF $WIX $TWOU $BEP $KEM $NOG $NTAP $SAGE $WB $VIAB $ROK $RETA $GO $TDW $ERJ
  • Ajax4Hire: ...
    $ABT $ABUS $ACIA $ADRO $AEM $AFL $AGCO $AGX $AIG $ALGN $ALKS $ALL $AMP $AMT $ANAB $ANF $ANTM $AOBC $APA $APT $APYX $ASH $ASIX $AYI $BAX $BCRX $BEAT $BIDU $BIIB $BKD $BKNG $BLMN $BLOK $BMY $BOOM $CACC $CALA $CARS $CCI $CDE $CELG $CENT $CGEN $CHK $CLV ...
  • Aragorn: @Ajax4Hire $ABT $ABUS $ACIA $ADRO $AEM $AFL $AGCO $AGX $AIG $ALGN $ALKS $ALL $AMP $AMT $ANAB $ANF $ANTM $AOBC $APA $APT $APYX $ASH $ASIX $AYI $BAX $BCRX $BEAT $BIDU $BIIB $BKD $BKNG $BLMN $BLOK $BMY $BOOM $CACC $CALA $CARS $CCI $CDE $CELG $CENT $CGEN ...
  • traderbren: $FOLD - could be the start of the next leg. Long.
  • eacain: @icbusiness $FOLD thanks! What software do you use to show insider buying/selling?
  • icbusiness: @eacain $FOLD Finviz (free) and biopharmcatalyst.com...it just backed off resistance a bit just now - I may buy more
  • icbusiness: $FOLD Institutional buying by Perceptive Advisers (see chart) ,who have a good record in Biotech - their last 10% buy at $13.56. more bought earlier- May run up into May 15 data release. Another nice move just now $15.19 at resistance of recent high at $15.19 R1 was 15.13 today. [Update - it backed off resistance - now 15.06] Research area: ATB200 Pompe Disease Phase 1/2 2Q 2018 06/30/2018 Phase 1/2 additional data released February 15, 2017, MAY 15, 2017 and October 4, 2017. Further update February 7, 2018 showed 6MWT distance of 25 meters at 9 months and 57 meters at 12 months. Regulatory update due 2Q 2018.
  • woodman: @eacain $FOLD #Insider Activity - Here's a great site, one I've posted many times in the past, to track insider activity. http://openinsider.com/search?q=fold
  • icbusiness: @woodman $FOLD #Insider Thank U - Perceptive Advisors have been accumulating while the corp officers are mainly selling
  • Bridget: $FOLD is breaking out on good volume. Breakout on the weekly. High IV in this biotech.
  • woodman: $SRPT $ARRY $CLVS $FOLD in #Biotech land. Possibly $EXEL and $SGYP as well.
  • infocus: $FOLD Small starter @15.60
  • infocus: $FOLD Stopped out - tiny loss.
  • traderbren: $FOLD - took $FOLD off the table. Been holding from lower level. I think its best to bank it for now.
  • Dan1946: $FOLD > bought at $ 15.55. Tried to put a stop @ $ 15.05. My Fidelity Account told me that couldn’t be set that way, to far away? I thought I would watch. The next time I looked it was under $ 15.00. I know nothing is guaranteed > this stinks!
  • infocus: @Dan1946 $FOLD Live and learn. Try TD Ameritrade, that won't happen. Many people in the Forum have accounts there, as do I. Just a suggestion.
  • clamtown: @Bridget $XLP $GIS $K $CPB $KHC $XRT $M $KR $COH $XOP $ESV $RIG $MRO $APC $CVE $XLI $XBI $SMH $MCHP $AMAT $AAPL $AVGO $SWKS $ADBE $MLCO $BBBY $BBRY $FDX $FOLD $PX $NOC $TWX $ROP $ALNY $VST $TSG $BEDU $ADNT $SNDR #Notes $AXP You mentioned this one the other day. Any changes.
  • Bridget: $FOLD day 2 of this breakout
  • bRobert: @Bridget $FOLD Great charts
  • issues: @Bridget $FOLD exhaustion high?
  • Bridget: @issues $FOLD It was very overextended so we're getting a pullback. But Entry point was around $15. I wouldn't be too worried about this unless it dips below that.
  • Bridget: #Notes $XLP - these consumer products were down on $GIS earnings $K $CPB $KHC $XRT - retail stocks falling lower $M $KR $COH $XOP - oil performing well. Good liquid stocks $ESV $RIG $MRO $APC $CVE $XLI - hit new highs $XBI - close to breaking higher out of flag $SMH - this rally is fizzling $MCHP $AMAT $AAPL - broke support at he 50dMA, $AVGO $SWKS - breaking down $ADBE - struggling to hold trendline after earnings $MLCO - gapped up this morning but then sold off $BBBY - hit a new low after earnings Breakouts $BBRY $FDX $FOLD $PX $NOC $TWX $ROP $ALNY IPOs working $VST $TSG $BEDU $ADNT $SNDR
  • bRobert:
  • Bridget: @bRobert $XLP $GIS $K $CPB $KHC $XRT $M $KR $COH $XOP $ESV $RIG $MRO $APC $CVE $XLI $XBI $SMH $MCHP $AMAT $AAPL $AVGO $SWKS $ADBE $MLCO $BBBY $BBRY $FDX $FOLD $PX $NOC $TWX $ROP $ALNY $VST $TSG $BEDU $ADNT $SNDR #Notes I agree that this is likely just a pause, not a top.
  • debeers: $FOLD-Know when to walk away, know when to run. You gotta know that Amicus ($FOLD) is abandoning its wound therapy. Short Snort Boy was I wrong about this one today. I guess Frosty is buying more shares.(Dr. Frost).
  • Mpower27: @debeers $FOLD looking at today's stick, wouldn't inspire confidence if I was long.
  • traderbren: $FOLD -- getting close to popping the top.
  • woodman: $FOLD - still consolidating but making a move since pulling back to the 50 day. It too has data coming -- by end of the quarter, I believe.
  • tjv821: $fold ??
  • traderbren: $FOLD - np, but looks constructive. Also noticed Sept $10 calls are of interest.
  • woodman: @traderbren $FOLD - looks nice! Np.
  • Aragorn: I am reviewing list of 300 or so Biotechs under 20 dollars for inside day and week and noting some patterns I like I came across Halo as an inside week and the stock has been moving up $APOP rev strat week $BCLI rev strat week setup $FOLD in w and hammer $KURA Inside week Hammer looks higher $RVNC maybe done down hammer $XBIT Hammer weekly $ABEO 40 week support inside inside week
  • champ: $FOLD looks like a BreakOut here...off of earnings $7.40 now not going to give it more than $0.25....trailing stop.
  • captron: @champ $FOLD Thanks for posting. Followed you in.
  • champ: @captron $FOLD ----@ $7.73 now... I think it might be able to get to $8 before it runs into ....Resistance ....short interest is appx 23% of the float.....I added a little.
  • captron: @champ $FOLD Short interest is my reason for jumping in. Will be watching with your .25 stop running
  • woodman: $FOLD - example 8,429 for why not to invest in individual small/mid cap biotech companies.
  • TunaHelper: @woodman $HALO Thx for the info. Setup seems to be pretty good, though I am not too inspired by the volume today. Another one I am looking at is $FOLD.
  • woodman: @TunaHelper $HALO $FOLD -FOLD too has some 4Q activity/catalysts. My notes on $FOLD say: 4Q16 - regulatory update for Fabry drug following NDA filing delay from prior mtg with FDA; 4Q16 - Phase 2 interim data for Pompe drug; 1H17 - Phase 3 data for EB drug
  • woodman: $FOLD - continues with good action, now moving up thru resistance. It has a meeting with the FDA on 9/30 regarding an NDA for its fabry disease drug so a regulatory update is expected thereafter I guess early 4Q. Other catalysts coming in 4Q as well.
  • woodman: @woodman $FOLD Actually, I'm not certain if that meeting is on 9/30. A regulatory update is due 4Q.
  • traderbren: $FOLD -- moving higher.
  • Bridget: $FOLD is breaking out of a tight squeeze. Still getting rejected at $8 though.
  • woodman: $FOLD peeking above the 200 day.
  • Lavrock: @woodman $FOLD Significant number of outstanding calls, particularly the Jan 10. Decent numbers for Oct 6, 7 and 8 calls. All bullish.
  • woodman: @Lavrock $FOLD Thanks. I like the action and do have some. It has "Q4" catalysts.
  • Bridget: $FOLD breaking out above the 200MA today. Will look to buy on the next pullback to the 20MA
  • woodman: $FOLD added on move up through the 200 day.
  • woodman: @steve71 $BMRN $INCY $REGN - Speaking of $BMRN and $INCY, see below.... I like $EXEL as a potential buyout too, which also is mentioned below. (Also mentioned is $FOLD, which I'm long). Goldman lists companies to be in focus after Medivation deal After Pfizer (PFE) announced it has agreed to acquire Medivation (MDVN) for $81.50 per share in cash, Goldman Sachs analyst Salveen Richter said he expects a focus on other commercial small-to-mid-cap cancer companies, including Incyte (INCY), Seattle Genetics (SGEN), ARIAD (ARIA) and Exelixis (EXEL). Also noting that Sanofi (SNY), which was pursuing Medivation, has recently suggested an interest in a rare disease transaction up to potentially as large as $20B, he would expect rare disease companies of that size - such as BioMarin (BMRN), Amicus (FOLD) and Ultragenyx (RARE) - to be in focus as well. Read more at: http://thefly.com/landingPageNews.php?id=2421216
  • steve71: @woodman $BMRN $INCY $REGN $EXEL $FOLD Good list, thanks. Last week I noted that BioMarin has an addressable market of up to $4B, the current cost of Factor 8 replacement in Hemophilia A.
  • Bridget: ...
    $FOLD - phase 2
    $DOW - at the top of its trading range, channeling stock
    $YELP - breaking out today, will it follow the movement of $GRPN and $GRUB
    $TAP - big reversal, sin stocks back up today
    $PTHN - ipo new high
  • woodman: $FOLD - Big volume yesterday and today. Is something up with this one? I don't know. But in response to someone's recent question asking me about biotechs I thought could be bought out, I provided a list of my small biotechs that I've been accumulating (not exclusively b/c of buyout potential but that possibility goes hand in hand with why I've been buying them since I believe in their drugs' or drug candidates' potential and attractiveness to the Market) since they've been dumped. FOLD is one I mentioned that I've been accumulating.
  • Alexandra: @woodman $GILD $RLYP $MDVN $CEMP $DVAX $FOLD $ACAD $AKRX $OPHT $GWPH $NVAX I may be a candidate for your basement if oil doesn't turn back up. Just teasing. I have stop losses in place. I hope I don't get stopped out of positions unrelated to oil. I guess we'll see in a few hours.
  • woodman: @gwenzee @Alexandra $GILD Every biotech I own has the chance, at some point, to be bought out. Doesn't mean they will be. Or, if they are, that it will happen any time soon. I didn't even sell my $RLYP due to the slim - probably extremely slim - chance that another suitor will make a better offer. Worse comes to worse, I'll get the $32. We'll know sooner rather than later b/c the Galencia deal will conclude pretty quickly. (RLYP isn't actively soliciting another buyer, but it can't ignore an offer if someone wants to make one.) Additionally, I own $MDVN $CEMP $DVAX $FOLD $ACAD $AKRX $OPHT $GWPH. $NVAX is a good one too, but I don't currently own it. As you can see, many are not based on the performance of their charts; of these poor performers, I've been accumulating here in the basement for their future potential.
  • Alexandra: @woodman $GILD $RLYP $MDVN $CEMP $DVAX $FOLD $ACAD $AKRX $OPHT $GWPH $NVAX Thanks. I wish they would buy $TRXC, $CELG, or $SRPT.
  • woodman: #Biotech Stocks - So many biotech stocks with a similar chart yesterday - i.e. pushing on resistance recent highs within consolidation and on the verge of breakouts. It had me buying or adding to a number of biotech stocks yesterday. Many breaking out today. Look at $ACAD $AKRX $OPHT $REGN. Today I added to $DVAX and $FOLD. $CEMP on my list too, but no position as I speak. That may change soon. Possible buyout potential in these, though may take a while.
  • woodman: $FOLD - moving up still from last week's European approval of migalstat for Fabry disease. http://www.xconomy.com/new-york/2016/05/31/amicus-nabs-first-approval-as-eu-gives-green-light-to-fabry-drug/#
  • Kid2old: @Aragorn $AAL $ADBE $ADRO $ALK $ALNY $AMZN $APA $ASPS $ATI $ATVI $BIB $BIDU $BMY $CA $CAKE $CANF $CBRL $CBS $CEMP $CENX $CMG $COG $COR $CORE $COST $CRM $CSX $CTL $CTRP $CTSH $CVLT $DATA $DIS $DPLO $DRI $DSX $EAT $EBAY $EQIX $EXPE $FBIO $FDX $FOLD $FRSH $FTI $GOOG $GOOGL $GWW $HERO $HLF $IBB $ILMN $INSY $IP $ITB $JBHT $JUNO $KMI $LAKE $LJPC $LL $LNKD $LOCO $LOW $LVLT $LVS $MLNX $MSFT $MXL $MYGN $NDAQ $NDLS $NOC $NTES $NVDA $ONVO $ORCL $PM $QLD $QQQ $R $RAX $RDUS $RENN $RH $RL $RMBS $RWLK $SAVE $SDRL $SGY $SINA $SLCA $SU $SVXY $SWHC $SWN $SYNA $TASR $TDW $TQQQ $TREX $TROV $TSCO $TSLA $UA $ULTI $UTX $UVXY $V $VA $VISN $VIXY $VRX $VXX $WHR $WY $XHB $XIV $XLK $XLY $XOMA $XONE
  • tradeforfamily: @gwenzee $IBB $CELG $BIIB $GILD $ALXN $REGN $SRPT $INCY $BPMC $ARGS I am long $FOLD and $CLDX.
  • kcar21966: $FOLD halted http://finance.yahoo.com/news/amicus-gets-positive-eu-regulator-153003205.html
  • woodman: @kcar21966 $FOLD http://www.thestreet.com/story/13515488/1/amicus-fabry-drug-takes-big-step-towards-european-approval.html
  • TRICIA: ...
    $FOLD upgraded to Buy from Neutral by Janney Capital. Price target raised to $12 (59% upside) from $10.

    $PTX downgraded to Market Perform from Outperform by Oppenheimer. $9 price target removed.

    $VRX downgraded to Neutral from Buy by Nomura. Pric ...
  • woodman: $ESPR $FOLD $HALO $CEMP - not aware of any immediate catalysts for these, but the charts are interesting to me. Maybe readying to move higher without immediate catalysts?
  • Bert953: Quite a few interesting charts: $AROC $ BCRX $ BKCC $ BLDR $CLCD $DRH $EFUT $FDX $FOLD $FXCM $KNL $KPTI $LABU $MKTO $PRU $RAS $TROV $TYL $UIS $WLL $XLK $ZIOP
  • woodman: @traderbren $RLYP #Biotech. I've done very little in the Market the last 2 weeks, preferring to sit it out in cash. But today a lot of bios are "successfully" testing support areas/lows. For how long this lasts, who knows. Biotech has been beaten up quite badly, and look like rubber bands stretched very tightly. $RLYP bounced right off the 11/13/2015 low, and is having a nice day. Also, $CEMP (I bought some back today) $DVAX $BLCM $FOLD just to name some I was looking at. My concern, however, is that it's just a very oversold bounce in many biotechs. There's a lot of supply above and, I assume, a lot of I want my money back folks. So I'm still not doing much and, mininally, want to see how these (and the market) close before saying it's time to start buying these back or adding significantly.
  • woodman: Some biotechs: $FOLD, $EXEL, $DVAX, $CEMP (long these currently). Congrats to anyone in $CLLS (no position).
  • woodman: $FOLD nice reversal.
  • woodman: $FOLD #Biotech - FOLD down 55% in the pre. No position, but it's been on my list for buy back. Biotech sooooooo under assault. Every day there’s some devastation on “bad” news – e.g., $FOLD, $TTPH, $ESPR. But even good news is massively sold into and then the stock ends up going even lower than where it was before the good news was announced. E.g., $ARWR, $HRTX. Or they are massively sold off on NO news – e.g., $EDAP. Just no way to win (if long) in biotech right now.
  • woodman: $FOLD - one helluva bounce. I played with it today and did fine, but nothing near what it could have been. I sold way too early.
  • janner0814: ...
    Good: (121 to 118) of 125: $NYCB $C $SUPN $VRX $BKU $PBCT $AMBA $FOLD $ORI $JPM $ACN


    Suggestion: Set your "pull back alert" to the 21 EMA or 20 SMA... pick your method, whatever it is; buy any of these on pull backs.
    * Since there is a "consisten ...
  • clefferts: $FOLD - added this morning, like the chart.
  • woodman: $FOLD - Amicus Therapeutics. Works on enzyme replacement therapies. I started buying this back on Friday (pullback to and bounce off 50 day) following my sale earlier in the week. It still has some room upward I think. Recent price targets have been hiked up. I've been in this for some and my sale was simply a function of not wanting to give back profits and thinking I could get back lower. That's always a gamble, but it worked this time. (Many times I have not pulled that off.)
  • woodman: @woodman $FOLD - Fyi - notwithstanding my prior post, here is a negative view on the company/stock. https://www.retailinvestor360.com/biotech/993-catching-shares-with-dr-tran-elucidating-the-investing-thesis-on-amicus-therapeutics.html
  • TRICIA: ...
    Cancer - $CLVS - gonna get bought $FOLD is considered a b/o ... and all the cart, gene editing ones too)

    watch $CLLS - tomorrow ...$XON and $ZIOP move together ... $SRNE - chart trade for now (I missed this but that's okay and the volume was incr ...
  • arrow: @dkoran $IBB - Not sure how you arrive at that, but go ahead if you like. You would be ignoring some blatant business conditions in the biotech area. Cash & Stock rich big biotech & specialty pharma all looking for assets. That's a really good backdrop for takeover speculation, coupled with a high approval rate of drugs in development. The $IBB is controlled by the big names, who go up when they buy growth (even if you can't stomach it). You want to short that? Short smaller names like $DEPO, $SGYP, $FOLD, $FLXN, $OPHT, and numerous others mentioned in the forum when a bid could be just around the corner? Good way to ruin a Sunday evening.
  • woodman: $FOLD continues higher.
  • clefferts: @woodman $FOLD -took some profits and reduced my position.
  • Aragorn: @mradams0621 Thx $FOLD daily chart a thing of beauty still walking up
  • woodman: $FOLD - nice last hour of trade to close with a hammer off the 8dEMA. Decent volume in that last hour and in last 5 minutes.
  • TRICIA: @Woodman, etall $FOLD, $TSRO and others - #Baker Bros Holdings ...FYI New Baker holdings w/overall rank & val 9 $NVTA 109M 10 $ONCE 102M 40 $LBIO 16M 51 $IMGN 9M 64 $TTHI 5M 65 $AMRN 5M 74 $ZFGN 4M 78 $ASMB 3M Baker Bros closed out $QLTI $FOLD $SGYP $GERN $TSRO
  • woodman: $FOLD - watch 11.25.
  • woodman: $FOLD nice bounce off 50 day.
  • woodman: @GreenGhost @Sox1317 $JUNO $IBB $XBI #Biotech - I tried a little JUNO last week, but it didn't work and I sold it near the open today with a negligible loss. JUNO is certainly ugly and broken, but IMO it's not about any one biotech stock today (unle ...
  • woodman: $FOLD - moving back above the 8dEMA.
  • woodman: $CLDX $ESPR $CEMP $FOLD $ZIOP $CMRX $TTPH $ONCE - just some biotech thoughts for you....
  • jltrader1: The following are this week's top 20 percentage gainers and top 20 percentage losers, categorized by sectors (over $300 mln market cap and 100K average daily volume). This week's top 20 % gainers Healthcare: $RTRX (22.34 51.36%), $ESPR (112.33 51%), $CORT (5.6 40%), $PRTA (38.66 34.84%), $INO (9.09 29.12%), $FOLD (11.61 25.51%), $JUNO (61.53 24.33%), $ATRA (38.78 23.42%), $AKRX (49.03 18.77%), $ITCI (27.64 17.72%) Materials: $GFI (4.36 18.16%) Industrials: $VLCCF (4.98 20.29%) Consumer Discretionary: $CTRP (57.58 31.31%), $QUNR (36.71 28.76%), $TLYS (16.7 27.09%), $CNV (6.65 18.54%) Information Technology: $VTSS (5.34 37.28%), $RALY (12.93 17.65%) Energy: $EXXI (3.83 25.57%), $WLB (29.25 19.34%) --------------------------------------------------------------------------------- This week's top 20 % losers Healthcare: $RDNT (7.54 -16.13%), $PGNX (6.06 -14.53%), $EPZM (19.91 -13.51%), $NKTR (12.02 -13.46%), $AMRN (2.52 -13.1%) Materials: $MTL (1.15 -25.32%), $SQM (18.86 -15.88%), $CLF (4.3 -12.96%) Industrials: $CVEO (2.41 -17.47%)$$NMM (9.75 -17.16%) Consumer Discretionary: $VNCE (16.77 -19.14%), $WTW (8.6 -17.86%) Information Technology: $DSKY (7.02 -35.12%), $YOKU (13.5 -15.04%), $MTSN (3.99 -14.38%), $HIMX (6.85 -14.16%) Financials: $ASPS (13.33 -25.15%), $EJ (5.1 -14.72%) Energy: $WG (3.07 -45.18%), $HGT (5.79 -13.71%) Hope this information is helpful. Have a great weekend.
  • moneyHoHo: If you are a holder of $FOLD, welcome to the party.
Visit the Trading Forum to join in the discussion.
Stock Price $10.57
Change 1.34%
Volume 215,530

Amicus Therapeutics, Inc.is a clinical-stage biopharmaceutical company is focused on the discovery, development and commercialization of a new class of orally-administered, small molecule drugs, for the treatment of a range of human genetic diseases.

Request Video of FOLD
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!